Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shom Goel

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2012
Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biologyShom Goel, Dai Fukumura, Rakesh K Jain
The Cochrane Database of Systematic Reviews|October 13, 2009
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenShom Goel, Rohini Sharma, Anne Hamilton, et al.
Nature Reviews. Cancer|March 19, 2022
Targeting CDK4 and CDK6 in cancerShom Goel, Johann S Bergholz, Jean J Zhao
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancerShom Goel, R John Simes, Jane M Beith
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Vascular normalization as a therapeutic strategy for malignant and nonmalignant diseaseShom Goel, Andus Hon-Kit Wong, Rakesh K Jain
Therapeutic Advances in Medical Oncology|July 25, 2018
CDK4/6 inhibition in breast cancer: current practice and future directionsSonia Pernas, Sara M Tolaney, Eric P Winer, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 15, 2004
Morphological changes and stress responses in neurons in cerebral cortex infiltrated by diffuse astrocytomaShom Goel, Stephen B Wharton, Laurence P Brett, et al.
Trends in Cell Biology|August 1, 2018
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle ArrestShom Goel, Molly J DeCristo, Sandra S McAllister, et al.
Cancer Research|February 27, 2013
Vascular normalization as an emerging strategy to enhance cancer immunotherapyYuhui Huang, Shom Goel, Dan G Duda, et al.
The Cochrane Database of Systematic Reviews|March 7, 2020
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancerKim Tam Bui, Melina L Willson, Shom Goel, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2012
Normalization of the tumor vasculature through oncogenic inhibition: an emerging paradigm in tumor biologyShom Goel, Dai Fukumura, Rakesh K Jain
The Cochrane Database of Systematic Reviews|October 13, 2009
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenShom Goel, Rohini Sharma, Anne Hamilton, et al.
Nature Reviews. Cancer|March 19, 2022
Targeting CDK4 and CDK6 in cancerShom Goel, Johann S Bergholz, Jean J Zhao
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancerShom Goel, R John Simes, Jane M Beith
Cold Spring Harbor Perspectives in Medicine|March 7, 2012
Vascular normalization as a therapeutic strategy for malignant and nonmalignant diseaseShom Goel, Andus Hon-Kit Wong, Rakesh K Jain
Therapeutic Advances in Medical Oncology|July 25, 2018
CDK4/6 inhibition in breast cancer: current practice and future directionsSonia Pernas, Sara M Tolaney, Eric P Winer, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 15, 2004
Morphological changes and stress responses in neurons in cerebral cortex infiltrated by diffuse astrocytomaShom Goel, Stephen B Wharton, Laurence P Brett, et al.
Trends in Cell Biology|August 1, 2018
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle ArrestShom Goel, Molly J DeCristo, Sandra S McAllister, et al.
Cancer Research|February 27, 2013
Vascular normalization as an emerging strategy to enhance cancer immunotherapyYuhui Huang, Shom Goel, Dan G Duda, et al.
The Cochrane Database of Systematic Reviews|March 7, 2020
Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancerKim Tam Bui, Melina L Willson, Shom Goel, et al.
Pageof 7